Newsletter

You Can't Be Serious

Total Labels 1
Approved 1
Expired 0

Jersey Spirits Distilling Co. — Fairfield, NJ

New Jersey

About You Can't Be Serious

You Can't Be Serious is a vodka brand with origin in New Jersey. The spirit is bottled at a proof level between 80 and 89, placing it within the standard range for vodka spirits. According to TTB public records, the brand maintains one distinct product offering within its vodka category. The brand received its single TTB label approval in 2021, establishing its official entry into the spirits market. As a vodka product registered with the Alcohol and Tobacco Tax and Trade Bureau, You Can't Be Serious meets the regulatory standards and labeling requirements applicable to spirits in this classification. The brand's presence in the vodka market reflects the broader category's continued prominence in American spirits consumption. Details regarding production methods, ingredient sourcing, taste profiles, or distribution networks remain outside the scope of TTB public registration data. For consumers seeking information about specific product characteristics or availability, consultation with retailers or the brand's official channels would provide more detailed guidance beyond what federal registration documents contain.

Filter by:
Displaying 1 results
Label Name Spirit Type Status Approval Date Producer
Vodka 80-89 Proof
You Can't Be Serious

VODKA 80-89 PROOF

Vodka 80-89 Proof Approved 2021-09-21 Jersey Spirits Distilling Co.

Page 1 of 1

1

You Can't Be Serious at a Glance

You Can't Be Serious has 1 distinct product with 1 total TTB label approvals, including Vodka 80-89 Proof. Labels approved between 2021-09-21 and 2021-09-21. Produced in New Jersey.

All information sourced from public TTB records.

Are you the owner or distributor of You Can't Be Serious?

Claim this brand listing to update information or get featured. Contact [email protected].

Produced At

Jersey Spirits Distilling CO.

Related Brands

Related Questions

Browse All Labels

Stay informed

Newsletter coming soon.

Follow us on X for new approvals, launches, and industry intelligence.